Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1891-1900 of 10640

Edit search filters
  1. Intraocular Pressure in Ocular Hypertensives with Scleral Lens Wear

    Rochester, MN

  2. Using Ice Around Postoperative Total Knee Incisions – Does This Make Sense?

  3. Reverse Total Shoulder Arthroplasty versus Nonoperative Treatment of 3 & 4-Part Proximal Humerus Fractures

    Rochester, MN

  4. A Study to Understand the Mechanisms of Normal and Disordered Defection

    Rochester, MN

  5. Study to Create a Registry to Collect the Findings and Outcomes of Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound (CE-EUS)

    Jacksonville, FL

  6. Personalized Smoking Cessation Tool Based on Patient Lung CT Image

    Rochester, MN

  7. Pilot Study of Between Visit Interaction to Improve Glycemic Control in Pregnancy With Pre-existing Diabetes

    Rochester, MN

  8. Pediatric and Adolescent Patellar Instability

    Rochester, MN

  9. A Phase 1 Dose Escalation and Expansion Study of TGR-1202 + Ruxolitinib in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (PPV-MF), Post-Essential Thrombocythemia MF (PET-MF), MDS/MPN, or Polycythemia Vera Resistant to Hydroxyurea

    Scottsdale/Phoenix, AZ

  10. Implementation of OR Active Microbreaks Using OR-Stretch Web Application to Reduce Surgeons’ Intraoperative Workload and Body Part Discomfort

    Jacksonville, FL

.

Mayo Clinic Footer